title: The Biosimilars Act: Promoting or Discouraging the Development of Generic Biologics?: A tug-of-war between generic and innovator biologics seems to be where drug developers are headed.
abstract: Congress may have unwittingly thrown roadblocks at makers of follow-on biologics.
authors.forename: Joanna T
authors.initials: JT
authors.lastname: Brougher